Parasitic Diseases Therapeutics Market, By Product Type (Antiprotozoal Therapeutics, Scabicides, Anthelminthic Therapeutics, Pediculicides Therapeutics and Others), By Application, By Distribution, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV5887
|
Published Date
August 2026
|
Pages
301
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Parasitic Diseases Therapeutics Market size was valued at US$ 1,590.2 Million in 2025, expanding at a CAGR of 4.1% from 2026 to 2033.
The parasitic disease therapeutics market is determined by the treatment of protozoan and helminthic infections, and includes antiprotozoal agents, anthelmintic drugs, scabicides, and pediculicides, produced as oral, topical, or combination therapeutics. Their manufacture involves the development of active pharmaceutical ingredients, formulation chemistry, sterile and non-sterile production, and quality control to meet the needs of mass treatment programs and individual prescriptions. In addition, hospitals and clinics are responsible for treating more severe forms of parasitic infections, while home use prevails for contagious skin infections and mild cases.
Therapeutics are designed to ensure appropriate dosing for children, address the threat of resistance, and provide the convenience of use. According to the WHO report, 56 countries have already interrupted one disease causing NTDs as of May 2025, which indicates ongoing efforts to control them, as well as the therapeutics market for parasitic diseases that addresses their treatment, prophylaxis, and the challenge of resistance.
Parasitic Diseases Therapeutics Market- Market Dynamics
Antiparasitic Resistance Is Rewriting Treatment Priorities
Drug resistance is now undermining the economic paradigm of treatment by eroding the efficacy of a number of successful antiparasitic regimens, prompting industry players to focus on expanding mechanisms of action, combination therapies, surveillance, and differentiated formulations. The threat of resistance is further projected to drive demand for sustainable supply chains, as even marginal deviations from the prescribed dosing schedules may undermine the effectiveness of treatment by promoting the development of parasite resistance. In its 2025 World Malaria Report, World Health Organization (WHO) has acknowledged the emergence of resistance to artemisinin, the latest addition to the antimalarial drugs, in eight African countries. Consequently, therapies with new modes of action, pediatric formulations, and other innovative approaches are gaining traction in the parasitic disease treatment market.
Parasitic Diseases Therapeutics Market- Segmentation Analysis:
The Global Parasitic Diseases Therapeutics Market is segmented on the basis of Product Type, Application, Distribution, and Region.
Antiprotozoal therapeutics are the largest product category, as malaria, amoebiasis, leishmaniasis, and other protozoan infections require specific treatment that is often determined at the country level in the public health sector. Oral formulations predominate for first-line treatment and are widely accessible, while severe forms of the disease need complex regimens that are administered in hospitals. The key differentiating factors are the availability of pediatric dosing, resistance mechanisms, convenience, and the potential to reduce transmission. According to the WHO report published in 2025, there are about 282 million confirmed cases of malaria across 80 endemic countries in 2024, which highlights the need for treatment. Antiprotozoal medications are a central element of control and management, and the main direction of development is resistance, including accessibility in endemic regions.
Anthelmintics, scabicides, pediculicides, and other products are indicated for disparate diseases but benefit from regular community-wide treatments, control of household spread, and prescriptions at primary healthcare levels. Compared to anthelmintics, topical treatments for ectoparasites require greater persistence, management at a household level, and repeat treatment. In 2025, 56 countries worldwide eliminated at least one neglected tropical disease (NTD), and 17 countries certified the elimination of an NTD between January 2023 and May 2025. The competitive position of each product is dictated by affordability, convenience of use, availability of treatment, outreach programs, and access to care.
Parasitic Diseases Therapeutics Market- Geographical Insights
A significant pharma manufacturing base, a generic drug capability, and several government initiatives dedicated to battling various infectious diseases contribute to the dominance of Asia-Pacific as a key therapeutic supplier and consumer. India, in particular, is a country that combines both the capacity to formulate domestic drugs and engage in large-scale government aid programs aimed at treating parasitic infections such as lymphatic filariasis, soil-transmitted helminthiases, and others. As the 2025 mass drug administration statistics for India show, 184,847,710 persons received treatment for lymphatic filariasis, indicating the government\'s extraordinary ability to procure treatment. Local manufacturing capabilities enable shorter supply chains and contribute to the rapid establishment of formulations that target local diseases, while its ability to manufacture high volumes of generic drugs serves to make these formulations economical to produce. Therefore, it can be stated that the region is an important contributor to both the treatment and the provision of pharmaceutical substances needed for it.
High endemicity, mass drug administration infrastructure, and a persistent transmission of malaria make Africa the biggest therapeutic market. The continent has treatment procurement focused on national ministries, international programs, community distribution chains, and donor-funded supplies. Moreover, it has an urgent need for diverse therapeutic options due to growing drug resistance. According to the WHO\'s Malaria report of 2025, 265 million cases of malaria were recorded in the African region in 2024, which makes up 94% of the world\'s total cases. Such a significant number of cases emphasizes the importance of pediatric formulations, decentralized treatment schemes, and increased monitoring of resistance trends. The African market is an important region where the success of a medical product depends on its performance in practice and commercialization strategy in terms of logistics and access.
Parasitic Diseases Therapeutics Market- Competitive Landscape:
Competition in the market is now defined by therapeutic differentiation and public health implementation, not volume and breadth of portfolio. The big pharmaceutical companies address a variety of antiparasitic medicinal products through a combination of existing high-quality products, pediatric reformulation, resistance research, robust manufacturing, regulatory expertise, and alliances with public health institutions. For instance, the 2025 Annual Report of Novartis revealed that 2.3 million molecules were screened to identify a new treatment for malaria. The company\'s executive summary highlights the novel mechanism of action of the isolated ganaplacide, which was incorporated into GanLum. The target product profile reflects the need for therapeutic options to combat resistant parasites and ensure better access to treatment. Therefore, the competitive landscape is defined by the creation of differentiated mechanisms of action, adapted delivery forms for children, clinical proof of concept, robust manufacturing to ensure supply, and geographic treatment access strategies.
Recent Developments:
- In July 2025, Novartis: Coartem Baby received Swissmedic approval as the first treatment for malaria in newborns and young children. The new formulation was developed to address the lack of appropriate therapy in this vulnerable population and is intended for use in malaria-endemic countries through Medicines for Malaria Venture.
- In November 2025, Novartis: GanLum met the primary endpoint of the Phase III KALUMA malaria study. The combination therapy under investigation showed a 97.4% PCR-corrected cure rate and has a novel mode of action, with its ganaplacide component targeting resistant malaria parasites.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amneal Pharmaceuticals LLC
- Bayer AG
- GSK Plc
- Johnson & Johnson Services, Inc.
- Cipla Ltd
- Merck KGaA
- Novartis AG
- Pfizer, Inc.
- Sanaria Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals USA, Inc.
- Reese Pharmaceutical Company
- Victor Medical Company
- Zydus Pharmaceuticals (USA) Inc.
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Antiprotozoal Therapeutics
- Scabicides
- Anthelminthic Therapeutics
- Pediculicides Therapeutics
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinic
- Hospital
- Homecare Setting
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. Parasitic Diseases Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Parasitic Diseases Therapeutics Key Market Trends
3.1. Parasitic Diseases Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Parasitic Diseases Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Parasitic Diseases Therapeutics Market Opportunities
3.4. Parasitic Diseases Therapeutics Market Future Trends
4. Parasitic Diseases Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Parasitic Diseases Therapeutics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Parasitic Diseases Therapeutics Market Landscape
6.1. Parasitic Diseases Therapeutics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Parasitic Diseases Therapeutics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Antiprotozoal Therapeutics
7.1.3. Scabicides
7.1.4. Anthelminthic Therapeutics
7.1.5. Pediculicides Therapeutics
7.1.6. Others
8. Parasitic Diseases Therapeutics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Clinic
8.1.3. Hospital
8.1.4. Homecare Setting
8.1.5. Others
9. Parasitic Diseases Therapeutics Market – By Distribution
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution, 2025 & 2033 (%)
9.1.2. Retail Pharmacies
9.1.3. Hospital Pharmacies
9.1.4. Online Pharmacies
9.1.5. Others
10. Parasitic Diseases Therapeutics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Parasitic Diseases Therapeutics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Parasitic Diseases Therapeutics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Parasitic Diseases Therapeutics Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Parasitic Diseases Therapeutics Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Parasitic Diseases Therapeutics Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Parasitic Diseases Therapeutics Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Amneal Pharmaceuticals LLC
11.2.2. Bayer AG
11.2.3. GSK Plc
11.2.4. Johnson & Johnson Services, Inc.
11.2.5. Cipla Ltd
11.2.6. Merck KGaA
11.2.7. Novartis AG
11.2.8. Pfizer, Inc.
11.2.9. Sanaria Inc.
11.2.10. Sanofi SA
11.2.11. Sun Pharmaceutical Industries Ltd.
11.2.12. Teva Pharmaceuticals USA, Inc.
11.2.13. Reese Pharmaceutical Company
11.2.14. Victor Medical Company
11.2.15. Zydus Pharmaceuticals (USA) Inc.
11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amneal Pharmaceuticals LLC
- Bayer AG
- GSK Plc
- Johnson & Johnson Services, Inc.
- Cipla Ltd
- Merck KGaA
- Novartis AG
- Pfizer, Inc.
- Sanaria Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals USA, Inc.
- Reese Pharmaceutical Company
- Victor Medical Company
- Zydus Pharmaceuticals (USA) Inc.
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Antiprotozoal Therapeutics
- Scabicides
- Anthelminthic Therapeutics
- Pediculicides Therapeutics
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinic
- Hospital
- Homecare Setting
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
GLOBAL PARASITIC DISEASES THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
